(EMAILWIRE.COM, March 06, 2019 ) The non-invasive prenatal testing market is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market.

The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.

The NIPT market is segmented based on product, method, application, end user, and region. On the basis of product, the market is segmented into consumables and instruments. The consumables segment offer lucrative growth opportunities and represent a new revenue pocket for the market owing to the repeated requirements of consumables in NIPT. The consumables segment is further divided into assay kits & reagents and disposables. The instruments segment is classified into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments.

On the basis of application, the NIPT market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest application segment and is slated to grow at the highest CAGR during the forecast period. This is mainly attributed to the increasing maternal age and rising incidence of chromosomal abnormalities.

To get Details @ https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

Currently, North America dominates the market, followed by Europe. However, the market in Asia is expected to witness the highest growth due to the increasing healthcare infrastructure. In addition, increasing awareness programs, rising disposable income, and increasing interest of players to expand in these emerging economies will propel the growth of the market.